oseltamivir has been researched along with Co-infection in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (66.67) | 24.3611 |
| 2020's | 7 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brock, M; Fremau, A; Humblet-Baron, S; Jacobs, C; Laeveren, B; Lagrou, K; Naesens, L; Ostyn, T; Reséndiz-Sharpe, A; Seldeslachts, L; Van De Veerdonk, FL; Vande Velde, G; Vanderbeke, L; Verbeken, E; Wauters, J | 1 |
| Cai, T; De Clercq, E; Huang, J; Ji, C; Li, G; Li, Z; Liu, Q; Luo, L; Luo, R; Tan, X; Wang, Y; Whitley, R; Xu, M; Yin, Q; Yue, T; Zhang, P; Zheng, Y | 1 |
| Fujisaki, S; Hashimoto, K; Hosoya, M; Katayose, M; Nemoto, K; Sakai, N; Sato, M; Takashita, E | 1 |
| Desvergez, A; Gazaille, V; Lilienthal, F; Paganin, F; Verdier, V; Winer, A | 1 |
| Hashizume, H; Konishi, T; Matsubara, H; Naito, A; Nakayama, S; Saito, K; Sugisawa, J; Takebayashi, K | 1 |
| Alsultan, M; Ishaqui, AA; Khan, AH; Khan, I; Syed Sulaiman, SA | 1 |
| Cahyadi, A; Henrina, J; Pusparani, A | 1 |
| Cooper, MJ; Darling, N; Doepking, M; Harris, S; Hawksworth, AW; Kremer, P; Myers, CA; Sanchez, JL; Steiner, SC; Swanson, KC | 1 |
| Liu, J; Long, X; Luo, H; Pan, X; Shen, F; Wang, S; Wu, J; Yao, L; Yuan, T | 1 |
| Hasegawa, T; Hirotsu, N; Saisho, Y | 1 |
| Bielefeld-Buss, AJ; Boucher, CA; Faber, HJ; Lutisan, JG; Maaskant, J; Ott, A; van Kampen, JJ | 1 |
| Adamou, E; Chen, X; Conrad, T; Hoppe, C; Karsch, K; Muehlhans, S; Obermeier, P; Peiser, C; Rath, B; Schweiger, B; Seeber, L; Tief, F; von Kleist, M | 1 |
| Jurek, T; Kuchar, E; Rorat, M; Szenborn, L | 1 |
| Cheung, PP; Choy, KT; Guan, Y; McKimm-Breschkin, JL; Ng, IH; Peiris, JS; Webby, RJ; Webster, RG; Wong, DD; Yen, HL; Zhou, J; Zhu, H | 1 |
| Homma, T; Imamura, Y; Iwanaga, N; Izumikawa, K; Kajihara, T; Kakeya, H; Kitano, M; Kohno, S; Kurihara, S; Miyazaki, T; Nakamura, S; Seki, M; Tanaka, A; Yanagihara, K | 1 |
| Norris, A; Sandrock, CE | 1 |
| Homma, T; Kitano, M; Kobayashi, M; Naito, A; Onishi, M; Sato, A; Taniguchi, K; Yoshinaga, T | 1 |
| Boianelli, A; Bruder, D; Hernandez-Vargas, EA; Sharma-Chawla, N | 1 |
| Koay, ES; Lee, CK; Lee, HK; Loh, TP; Tambyah, PA; Tang, JW | 1 |
| Brydak, LB; Donevski, S; Gawryluk, D; Romanowska, M; Stefanska, I | 1 |
| Asgeirsson, H; Baldursson, O; Bjarnason, A; Gottfredsson, M; Gudnason, JF; Hallgrimsson, KL; Haraldsson, G; Kristinsson, KG; Kristjansdottir, BS; Löve, A; Thorleifsdottir, G | 1 |
1 review(s) available for oseltamivir and Co-infection
| Article | Year |
|---|---|
Infection in severe asthma exacerbations and critical asthma syndrome.
Topics: Animals; Asthma; Azithromycin; Bacterial Infections; Ceftriaxone; Coinfection; Critical Illness; Disease Progression; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Seasons; Syndrome | 2015 |
20 other study(ies) available for oseltamivir and Co-infection
| Article | Year |
|---|---|
Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model.
Topics: Animals; Aspergillosis; Aspergillus; Aspergillus fumigatus; Coinfection; Disease Models, Animal; Humans; Influenza, Human; Invasive Pulmonary Aspergillosis; Mice; Oseltamivir; Pulmonary Aspergillosis; X-Ray Microtomography | 2021 |
Comparative effectiveness of oseltamivir versus peramivir for hospitalized children (aged 0-5 years) with influenza infection.
Topics: Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Coinfection; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Treatment Outcome | 2023 |
Clinical and Virologic Impacts of Respiratory Viral Co-infections in Children With Influenza.
Topics: Antiviral Agents; Child; Coinfection; Humans; Influenza, Human; Oseltamivir; Virus Diseases; Viruses | 2023 |
Severe forms of influenza infections admitted in intensive care units: Analysis of mortality factors.
Topics: Adult; Coinfection; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Oseltamivir; Pneumonia; Respiratory Distress Syndrome; Retrospective Studies | 2023 |
Herpes zoster duplex in a patient with influenza A and bacterial superinfection.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antiviral Agents; Coinfection; Herpes Zoster; Humans; Influenza A virus; Influenza, Human; Male; Oseltamivir; Streptococcal Infections; Superinfection; Tonsillitis; Torso; Valacyclovir | 2020 |
Assessment of Antiviral combination therapy with Cephalosporin antibiotic for prevention of severe Influenza-A (H1N1)pdm09 infection associated secondary bacterial infection and other complications.
Topics: Antiviral Agents; Bacterial Infections; Cephalosporins; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir | 2020 |
Co-infection of COVID-19 and recurrent malaria.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Humans; Indonesia; Malaria; Male; Oseltamivir; Recurrence; SARS-CoV-2; Young Adult | 2021 |
Outbreak of influenza and rhinovirus co-circulation among unvaccinated recruits, U.S. Coast Guard Training Center Cape May, NJ, 24 July-21 August 2016.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adult; Antiviral Agents; Coinfection; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Influenza, Human; Male; Military Personnel; New Jersey; Oseltamivir; Picornaviridae Infections; Respiratory Tract Infections; Rhinovirus; Young Adult | 2018 |
Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Coinfection; Female; Fluoroquinolones; Humans; Immunoglobulins; Influenza A Virus, H7N9 Subtype; Influenza, Human; Methylprednisolone; Moxifloxacin; Mycoplasma pneumoniae; Oseltamivir; Pneumonia, Mycoplasma | 2018 |
The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Coinfection; Enzyme Inhibitors; Family Characteristics; Female; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Japan; Male; Middle Aged; Neuraminidase; Oseltamivir; Prospective Studies; Young Adult | 2019 |
Case report: oseltamivir-induced resistant pandemic influenza A (H1N1) virus infection in a patient with AIDS and Pneumocystis jirovecii pneumonia.
Topics: Adult; Antiviral Agents; Coinfection; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumocystis carinii; Pneumonia, Pneumocystis | 2013 |
Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.
Topics: Antiviral Agents; Child; Child, Preschool; Coinfection; Drug Resistance, Viral; Early Diagnosis; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Patient Isolation; Precision Medicine; Respiratory Tract Infections; Viral Proteins | 2013 |
The clinical course of late diagnosed fatal cases of A (H1N1) influenza in Poland.
Topics: Adult; Age of Onset; Aged; Antiviral Agents; Arthritis; Cause of Death; Coinfection; Comorbidity; Cross Infection; Delayed Diagnosis; Disease Progression; Fatty Liver; Female; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia; Poland; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Survival Rate; Young Adult | 2013 |
Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.
Topics: Acids, Carbocyclic; Amino Acid Substitution; Antiviral Agents; China; Coinfection; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Viral Plaque Assay; Viral Proteins; Zanamivir | 2013 |
The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
Topics: Acids, Carbocyclic; Administration, Intravenous; Administration, Oral; Animals; Antiviral Agents; Chemokine CXCL2; Chemokines; Coinfection; Cyclopentanes; Guanidines; Influenza A Virus, H1N1 Subtype; Interferon-gamma; Interleukin-6; Lung; Male; Mice; Mice, Inbred CBA; Orthomyxoviridae Infections; Oseltamivir; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Topics: Acids, Carbocyclic; Administration, Intravenous; Animals; Antiviral Agents; Bacterial Load; Coinfection; Cyclopentanes; Cytokines; Disease Models, Animal; Dogs; Guanidines; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Pneumococcal Infections; Streptococcus pneumoniae; Viral Load; Virus Replication | 2015 |
Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.
Topics: Anti-Bacterial Agents; Antiviral Agents; Coinfection; Computer Simulation; Humans; Influenza A virus; Influenza, Human; Models, Theoretical; Neuraminidase; Oseltamivir; Pneumococcal Infections; Streptococcus pneumoniae | 2016 |
High-resolution melting approach to efficient identification and quantification of H275Y mutant influenza H1N1/2009 virus in mixed-virus-population samples.
Topics: Antiviral Agents; Coinfection; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutant Proteins; Mutation, Missense; Neuraminidase; Oseltamivir; Sensitivity and Specificity; Transition Temperature; Viral Load; Viral Proteins | 2011 |
Co-infections with influenza and other respiratory viruses.
Topics: Adult; Aged; Alphainfluenzavirus; Antiviral Agents; Child, Preschool; Coinfection; Coronavirus; Coronavirus Infections; Female; Humans; Immunocompromised Host; Influenza, Human; Male; Middle Aged; Oseltamivir; Parainfluenza Virus 3, Human; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections | 2013 |
Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Coinfection; Community-Acquired Infections; Comorbidity; Female; Humans; Iceland; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Male; Middle Aged; Mycoplasma pneumoniae; Oseltamivir; Pandemics; Patient Admission; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Streptococcus pneumoniae | 2012 |